These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 380160)

  • 21. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK; Blau N
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Social quotients of children with phenylketonuria before and after discontinuation of dietary therapy.
    Matthews WS; Barabas G; Cusack E; Ferrari M
    Am J Ment Defic; 1986 Jul; 91(1):92-4. PubMed ID: 3740120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Blood serum proteins studied by a method of polyacrylamide gel disc electrophoresis in children with phenylketonuria].
    Lupinovich VL; Kopylova NV
    Vopr Pitan; 1980; (6):24-6. PubMed ID: 7467230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of rapid increase of phenylalanine intake in older PKU children.
    Beckner AS; Centerwall WR; Holt L
    J Am Diet Assoc; 1976 Aug; 69(2):148-51. PubMed ID: 939895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of early started dietetic treatment on the bioelectric brain activity in children with phenylketonuria].
    Koślacz-Folga A; Cabalska B; Jackowska K
    Neurol Neurochir Pol; 1974; 8(6):815-21. PubMed ID: 4437712
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term beneficial effects of the phenylalanine-restricted diet in late-diagnosed individuals with phenylketonuria.
    Koch R; Moseley K; Ning J; Romstad A; Guldberg P; Guttler F
    Mol Genet Metab; 1999 Jun; 67(2):148-55. PubMed ID: 10356314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal.
    Landolt MA; Nuoffer JM; Steinmann B; Superti-Furga A
    J Pediatr; 2002 May; 140(5):516-21. PubMed ID: 12032515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fat intakes of children with PKU on low phenylalanine diets.
    Rose HJ; White F; Macdonald A; Rutherford PJ; Favre E
    J Hum Nutr Diet; 2005 Oct; 18(5):395-400. PubMed ID: 16150136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of early detected and early treated phenylketonuria patients.
    Rylance G
    Postgrad Med J; 1989; 65 Suppl 2():S7-9. PubMed ID: 2622815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein Substitutes in PKU; Their Historical Evolution.
    Daly A; Evans S; Pinto A; Ashmore C; MacDonald A
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33540516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Children with phenylketonuria (Fölling's disease). Intellectual functions and psychological adaptation].
    Aarseth J; Vandvik IH; Heyerdahl S; Kindt E; Motzfeldt K; Halvorsen S
    Tidsskr Nor Laegeforen; 1989 Nov; 109(33):3416-8. PubMed ID: 2609302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary management practices in phenylketonuria across European centres.
    Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
    Clin Nutr; 2009 Jun; 28(3):231-6. PubMed ID: 19362397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased plasma adiponectin concentrations in poorly controlled patients with phenylketonuria normalize with a strict diet: evidence for catecholamine-mediated adiponectin regulation and a complex effect of phenylketonuria diet on atherogenesis risk factors.
    Schulpis KH; Papassotiriou I; Tsakiris S; Vounatsou M; Chrousos GP
    Metabolism; 2005 Oct; 54(10):1350-5. PubMed ID: 16154435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of patients with phenylketonuria in Mexico].
    Carnevale A; Velázquez A; Ruíz F; Del Castillo V
    Bol Med Hosp Infant Mex; 1979; 36(3):375-84. PubMed ID: 426919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of phenylketonuria. Principles, management and importance of a phenylalanine-free protein hydrolysate].
    Boisse J; Saudubray JM; Cathy T; Mozziconacci P
    Ann Pediatr (Paris); 1971 Feb; 18(2):109-17. PubMed ID: 5549952
    [No Abstract]   [Full Text] [Related]  

  • 37. Protein v. enzymic protein hydrolysates. Nitrogen utilization in starved rats.
    Boza JJ; Martínez-Augustin O; Baró L; Suarez MD; Gil A
    Br J Nutr; 1995 Jan; 73(1):65-71. PubMed ID: 7857916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acid-base status in dietary treatment of phenylketonuria.
    Manz F; Schmidt H; Schärer K; Bickel H
    Pediatr Res; 1977 Oct; 11(10 Pt 2):1084-7. PubMed ID: 904971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phenylalanine-restricted diet: the substitutes].
    Ogier H; Depondt E; Munnich A; Saudubray JM
    Arch Fr Pediatr; 1983; 40 Suppl 1():247-50. PubMed ID: 6882142
    [No Abstract]   [Full Text] [Related]  

  • 40. [Phenylketonuria--physical and mental development of phenylketonuric children subjected to early treatment].
    Cabral A; Portela R; Tasso T; Eusébio F; Guilherme A; Lorga L; De Almeida IT; Silveira C; Levy ML
    Acta Med Port; 1989; 2(1):1-5. PubMed ID: 2773674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.